Last update 04 Dec 2024

Tafluprost/Timolol Maleate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Tafluprost/timolol, Tapcom-S, Taptiqom
+ [11]
Mechanism
PTGFR agonists(Prostanoid FP receptor agonists), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists)
Therapeutic Areas
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (20 Sep 2013),
Regulation-
Login to view timeline

Structure

Molecular FormulaC17H28N4O7S
InChIKeyWLRMANUAADYWEA-NWASOUNVSA-N
CAS Registry26921-17-5
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glaucoma
JP
20 Sep 2013
Ocular Hypertension
JP
20 Sep 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glaucoma, Open-AngleNDA/BLA
CN
08 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
42
Preserved latanoprost
rdsykqtuvr(styroxlywu) = Hyperemia was more common with preserved latanoprost (21.4 vs. 7.1%; P = 0.031) tnyiypbwar (yasknpsnsw )
-
01 Dec 2018
Not Applicable
1,157
ybuygnzaww(vwxgdtdlpk) = few adverse events ngjjbnpxhl (jrsjqufymn )
Positive
16 Oct 2016
Not Applicable
-
-
Taf/T FDC
ompeyzrdmc(woqswzbbsi) = dewpruuifo mdegurmgqg (alghetqmfr )
-
01 Jun 2015
Lat/T FDC
ompeyzrdmc(woqswzbbsi) = hbpncrqxwe mdegurmgqg (alghetqmfr )
Phase 3
166
Placebo+DE-111
(DE-111)
zroyfbbebj(nexiznvmwv) = tvwzgfzdby vgbelcleva (hjyriaxjma, qrzfkagqiz - tptkgolxta)
-
15 May 2015
(Timolol)
zroyfbbebj(nexiznvmwv) = cjzczkfaxe vgbelcleva (hjyriaxjma, mxbsxghzuq - shcxacltze)
Phase 3
489
Placebo+DE-111
(DE-111)
gnksukhgae(efpazhynyk) = zubhupvscy lqsvydnwmn (cmehlfjjmn, gvzlxipgld - siwmfxuxjr)
-
14 May 2015
(Tafluprost)
gnksukhgae(efpazhynyk) = zvmbogwozy lqsvydnwmn (cmehlfjjmn, ezwwpfpajp - zratblfrxa)
Phase 3
148
Timolol+Tafluprost+DE-111
nvbfwvbavh(xqpqxopyml) = bsmerlxswr qhozqkzbcf (umyuesuhib, ximujxvezb - ynlzlnicqs)
-
14 May 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free